Lupin (NSE:LUPIN) Marketable Securities : ₹17,047 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Lupin's Marketable Securities for the quarter that ended in Mar. 2024 was ₹17,047 Mil.

Lupin's annual Marketable Securities declined from Mar. 2022 (₹10,143 Mil) to Mar. 2023 (₹6,743 Mil) but then increased from Mar. 2023 (₹6,743 Mil) to Mar. 2024 (₹17,047 Mil).

Lupin Marketable Securities Historical Data

The historical data trend for Lupin's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Marketable Securities Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

24,426.20

24,594.50

10,143.30

6,742.80

17,046.80

Lupin Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															6,742.80	-	7,794.20	-	17,046.80

Lupin Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Lupin (NSE:LUPIN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Lupin Marketable Securities Related Terms

Thank you for viewing the detailed overview of Lupin's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Marketable Securities

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines